Euclid Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-36,782
Closed -$2.9M 272
2016
Q2
$2.9M Buy
36,782
+17,990
+96% +$1.35M 0.13% 229
2016
Q1
$1.35M Sell
18,792
-32,576
-63% -$2.46M 0.05% 312
2015
Q4
$4.33M Buy
+51,368
New +$4.26M 0.13% 206
2015
Q3
Sell
-73,045
Closed -$6.1M 349
2015
Q2
$6.1M Sell
73,045
-282,925
-79% -$21.6M 0.12% 219
2015
Q1
$25.9M Buy
+355,970
New +$25.3M 0.48% 49
2014
Q4
Sell
-500,000
Closed -$32.4M 444
2014
Q3
$32.4M Buy
500,000
+30,220
+6% +$1.91M 0.23% 102
2014
Q2
$29.2M Sell
469,780
-74,076
-14% -$4.42M 0.21% 119
2014
Q1
$32M Buy
543,856
+146,590
+37% +$8.18M 0.24% 90
2013
Q4
$20.3M Sell
397,266
-20,430
-5% -$1.02M 0.17% 132
2013
Q3
$21M Buy
417,696
+86,646
+26% +$4.54M 0.21% 110
2013
Q2
$16.3M Buy
+331,050
New +$18M 0.21% 125

Other funds holding LLY

Euclid Advisors's LLY Position: Q3 2016 in Review

Euclid Advisors sold out of Eli Lilly (LLY) in Q3 2016, closing a stake of 36,782 shares — an estimated $2.9M sold.

Euclid Advisors first reported a position in LLY in Q2 2013 and held it in 11 quarters. The position peaked at $32.4M in Q3 2014. 1,177 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

  • Euclid Advisors reported no remaining Eli Lilly position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 36,782 Eli Lilly shares in Q3 2016, an estimated $2.9M.
  • Euclid Advisors first reported a position in Eli Lilly in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Eli Lilly position peaked at $32.4M in Q3 2014.
  • 1,177 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.